Transcripts Riot Platforms, Inc.

Actions

RIOT

US7672921050

Blockchain & Cryptomonnaies

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 06/03/2026			Varia. 5j.	Varia. 1 janv.
14,16 ^USD	-9,20 %		-17,12 %	+11,80 %

04/03	Wall Street surmonte les incertitudes liées à la guerre au Moyen-Orient	AW
04/03	Wall Street se reprend, aidée par une détente des prix du pétrole	AW

Transcripts

02/03	Transcript : Riot Platforms, Inc., Q4 2025 Earnings Call, Mar 02, 2026
16/01	Transcript : Riot Platforms, Inc. - Special Call
30/10/25	Transcript : Riot Platforms, Inc., Q3 2025 Earnings Call, Oct 30, 2025
31/07/25	Transcript : Riot Platforms, Inc., Q2 2025 Earnings Call, Jul 31, 2025
01/05/25	Transcript : Riot Platforms, Inc., Q1 2025 Earnings Call, May 01, 2025
24/02/25	Transcript : Riot Platforms, Inc., Q4 2024 Earnings Call, Feb 24, 2025
30/10/24	Transcript : Riot Platforms, Inc., Q3 2024 Earnings Call, Oct 30, 2024
31/07/24	Transcript : Riot Platforms, Inc., Q2 2024 Earnings Call, Jul 31, 2024
01/05/24	Transcript : Riot Platforms, Inc., Q1 2024 Earnings Call, May 01, 2024
14/12/22	Transcript : Riot Blockchain, Inc. - Special Call
27/05/21	Transcript : Riot Blockchain, Inc., Whinstone US, Inc. - M&A Call
08/04/21	Transcript : Riot Blockchain, Inc., Whinstone US, Inc. - M&A Call
12/11/20	Transcript : Riot Blockchain, Inc. - Shareholder/Analyst Call
14/09/16	Transcript : BiOptix Inc., Venaxis, Inc. - M&A Call
27/01/16	Transcript : Strand Life Sciences Private Limited, Venaxis, Inc. - M&A Call
24/06/15	Transcript : Venaxis, Inc. - Shareholder/Analyst Call
07/04/15	Transcript : Venaxis, Inc. - Special Call
13/02/15	Transcript : Venaxis, Inc. - Special Call
08/12/14	Transcript : Venaxis, Inc. - Special Call
11/08/14	Transcript : Venaxis, Inc. - Special Call
13/03/14	Transcript : Venaxis, Inc. - Special Call
07/11/13	Transcript : Venaxis, Inc., Q3 2013 Earnings Call, Nov 07, 2013
16/07/13	Transcript : Venaxis, Inc. - Special Call
26/03/13	Transcript : Venaxis, Inc., Q4 2012 Earnings Call, Mar 26, 2013
13/11/12	Transcript : AspenBio Pharma, Inc., Q3 2012 Earnings Call, Nov 13, 2012